221 related articles for article (PubMed ID: 12587840)
21. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway.
Chang WT; Kang JJ; Lee KY; Wei K; Anderson E; Gotmare S; Ross JA; Rosen GD
J Biol Chem; 2001 Jan; 276(3):2221-7. PubMed ID: 11053449
[TBL] [Abstract][Full Text] [Related]
22. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide.
Wang X; Matta R; Shen G; Nelin LD; Pei D; Liu Y
J Mol Med (Berl); 2006 May; 84(5):405-15. PubMed ID: 16385419
[TBL] [Abstract][Full Text] [Related]
24. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
25. Andrographis paniculata extracts and major constituent diterpenoids inhibit growth of intrahepatic cholangiocarcinoma cells by inducing cell cycle arrest and apoptosis.
Suriyo T; Pholphana N; Rangkadilok N; Thiantanawat A; Watcharasit P; Satayavivad J
Planta Med; 2014 May; 80(7):533-43. PubMed ID: 24782229
[TBL] [Abstract][Full Text] [Related]
26. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.
Zhao X; Zhang Q; Chen L
Oncol Rep; 2016 Sep; 36(3):1499-505. PubMed ID: 27461934
[TBL] [Abstract][Full Text] [Related]
27. Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.
Wu PP; Liu KC; Huang WW; Ma CY; Lin H; Yang JS; Chung JG
Oncol Rep; 2011 Feb; 25(2):551-7. PubMed ID: 21152873
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition.
Nateewattana J; Dutta S; Reabroi S; Saeeng R; Kasemsook S; Chairoungdua A; Weerachayaphorn J; Wongkham S; Piyachaturawat P
Eur J Pharmacol; 2014 Jan; 723():148-55. PubMed ID: 24360936
[TBL] [Abstract][Full Text] [Related]
30. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
[TBL] [Abstract][Full Text] [Related]
31. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.
Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M
Anticancer Res; 2012 Jun; 32(6):2249-56. PubMed ID: 22641659
[TBL] [Abstract][Full Text] [Related]
32. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
33. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
[TBL] [Abstract][Full Text] [Related]
34. Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells.
Chen YW; Lin GJ; Chuang YP; Chia WT; Hueng DY; Lin CK; Nieh S; Sytwu HK
Anticancer Drugs; 2010 Jun; 21(5):502-13. PubMed ID: 20154595
[TBL] [Abstract][Full Text] [Related]
35. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
36. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
[TBL] [Abstract][Full Text] [Related]
37. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Uslu R; Bonavida B
Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
[TBL] [Abstract][Full Text] [Related]
39. The anticancer effects of Resina Draconis extract on cholangiocarcinoma.
Wen F; Zhao X; Zhao Y; Lu Z; Guo Q
Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055
[TBL] [Abstract][Full Text] [Related]
40. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
